Processing your payment...
Please do not close your browser.

Gastroparesis Drugs Market - Global Growth, Trends and Forecast (2022 - 2029) By Types, By Application, By Regions and By Key Players: Teva (TLV: TEVA), Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), Vanda Pharmaceuticals (NASDAQ: VNDA)

27 Jun, 2022 | 116 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next Forecast years the Gastroparesis Drugs market will register a 4.9% CAGR in terms of revenue, the global market size will reach USD 6.93 billion by 2029.

Gastroparesis Drugs Market Overview

Gastroparesis is a stomach medical disorder that disrupts the stomach muscles' natural spontaneous motility. It impairs regular digestion, induces vomiting, and causes issues with blood sugar and nutrition. Gastroparesis is treated with a variety of pharmaceuticals and treatments, including reglan, erythromycin, antiemetics, and others.

The market is driven by an increase in the frequency of procedures that result in postsurgical gastroparesis, an increase in the diabetic population, an increase in the geriatric population, and the development of novel medications to treat symptoms including nausea and vomiting. However, adverse effects associated with gastroparesis medications, a time-consuming regulatory process for therapeutic approval, and challenges in gastroparesis diagnosis are limiting the market's expansion. In contrast, throughout the forecast period, a surge in demand for user-friendly medicine development, increased healthcare infrastructure, and innovative marketing strategies by leading vendors in emerging countries are likely to give profitable potential for market advancement.

What is our Gastroparesis Drugs Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2029 CAGR

 

CAGR of 4.9% during the review period (2022 to 2029).

 

By Type

  • Prokinetic Agents
  • Antiemetic Agents
  • Others

 

By Application

  • Diabetic Gastroparesis
  • Idiopathic Gastroparesis

 

 By Companies

 

 

 

 

Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm, Vanda Pharmaceuticals

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

 

Base Year

 

 

2022

 

Historical Year

 

 

2017 to 2021

Forecast Year

 

2022 to 2029

Number of Pages

116

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Gastroparesis Drugs Market?

The Gastroparesis Drugs Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva (TLV: TEVA), Johnson & Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), Vanda Pharmaceuticals (NASDAQ: VNDA), Kyowa Kirin Pharmaceuticals, Hanmi Pharm.

Industry News:

Dec. 3, 2018: Vanda Pharmaceuticals, Inc. (Vanda) (Nasdaq:VNDA) announced that tradipitant met the primary endpoint in VLY686-2301, a Phase II clinical study in patients with idiopathic and diabetic gastroparesis.  The study also presented that tradipitant was well tolerated with comparable rates of adverse events among the tradipitant and placebo groups.

Jan. 4, 2017 Sanofi announced today that Soliqua™ 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies. Soliqua 100/33 is indicated for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin (less than 60 Units daily) or lixisenatide.

What are the major Applications, Types and Regions for Gastroparesis Drugs Market?

By Type, it is segmented into

  • Prokinetic Agents
  • Antiemetic Agents
  • Others

By Applications it is segmented into

  • Diabetic Gastroparesis

Idiopathic Gastroparesis

Gastroparesis Drugs Market Regional Analysis

North America is likely to hold a significant market position in the gastroparesis medicine market due to an older population and an increase in surgical operations. According to the Centres for Disease Control and Prevention, around 84 million people in the United States have prediabetes in 2019, which leads to a high prevalence of gastroparesis condition and drives the market for gastroparesis drugs. Additionally, rising healthcare expenditures, an increase in the number of hospitals, and the presence of well-established healthcare infrastructure are all contributing to the overall regional market's growth.

Many companies will find the Asia-Pacific region to be a lucrative prospect, as nations such as India have a high prevalence rate of diabetes, which leads to gastroparesis condition and so contributes to the gastroparesis medicine market.

The market for Gastroparesis Drugs in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America

The Gastroparesis Drugs Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Gastroparesis Drugs Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
  4. Key Insights
    1. Pricing Analysis, By Key Regions, 2022
    2. Price Comparison (USD Per Ton) By Type (Prokinetic Agents, Antiemetic Agents, Others) 2021/2022
    3. Price Comparison (USD, Per Ton): By Application (Diabetic Gastroparesis, Idiopathic Gastroparesis) 2021/2022
    4. Impact of COVID-19 on the Gastroparesis Drugs Market
    5. Production Share of Gastroparesis Drugs, By Region, 2022
    6. Key Industry Developments
  5. Global Gastroparesis Drugs Market Analysis, Insights and Forecast, 2022-2029
    1. Market Analysis, Insights and Forecast – By Application
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
    2. Market Analysis, Insights and Forecast – By Type
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Teva (TLV: TEVA)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Johnson & Johnson (NYSE: JNJ)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Pfizer (NYSE: PFE)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Vanda Pharmaceuticals (NASDAQ: VNDA)
        1. Overview,
        2. Products,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla